Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - ORTHOPEDIATRICS CORP | exhbit322-cfocertification.htm |
| EX-31.2 - EXHIBIT 31.2 - ORTHOPEDIATRICS CORP | exhibit312-cfocertification.htm |
| EX-31.1 - EXHIBIT 31.1 - ORTHOPEDIATRICS CORP | exhibit311-ceocertification.htm |
| EX-24.1 - EXHIBIT 24.1 - ORTHOPEDIATRICS CORP | a19158663v1_exhibit24-poa.htm |
| EX-23.1 - EXHIBIT 23.1 - ORTHOPEDIATRICS CORP | deloitteconsent-10kfiling.htm |
| EX-21.1 - EXHIBIT 21.1 - ORTHOPEDIATRICS CORP | subsidiariesoforthopediatr.htm |
| 10-K - 10-K - ORTHOPEDIATRICS CORP | orthopediatrics10-k2017.htm |
CERTIFCATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of OrthoPediatrics Corp. (the “Company”) for the period ended December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Mark C. Throdahl, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company. |
/s/ Mark C. Throdahl |
Mark C. Throdahl |
President and Chief Executive Officer |
Date: March 15, 2018